UBE2L6 Antibody (N-term) Blocking Peptide

UBE2L6 Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP2118a
Catalog Number: AC-BP2118a
Size: 500 µg
Datasheet
Request Information
Background:
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). UBE2L6 is a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to function in the E6/E6-ap-induced ubiquitination of p53.

Other Names:
Ubiquitin/ISG15-conjugating enzyme E2 L6, Retinoic acid-induced gene B protein, RIG-B, UbcH8, Ubiquitin carrier protein L6, Ubiquitin-protein ligase L6, UBE2L6, UBCH8

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2118a was selected from the N-term region of human UBE2L6 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: UBE2L6

Gene ID: 9246
Primary Accession: O14933
Other Accession: NP_937826
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:UBE2L6 Antibody (N-term) Blocking Peptide